PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis

Nov 19, 2015, 08:00 ET from Big Market Research

PORTLAND, Oregon, November 19, 2015 /PRNewswire/ --

PharmaSphere: Emerging Biotechnologies Gene Therapy Market Analysis report is an essential source of information and analysis on the gene therapy field. Using detailed company data, deal analysis, corporate strategy, and market trends analysis, provides an in-depth analysis of the current and future growth drivers of the gene therapy market. The report discusses the key factors shaping and driving the gene therapy business, and provides insights on the competitive landscape and emerging strategies expected to significantly influence the market positions of companies currently involved in the development and commercialization of gene therapies.


For More Information Visit @

Key Questions Answered 

•What are the drivers of the gene therapy field?

•Who are the leading companies involved in the development of gene therapies?

•What are the major trends in gene therapy clinical trials?

•What specific therapeutic areas and indications are receiving the most clinical research?

•What progress has been made in terms of viral vector technology and gene delivery?

•What specific business development activities are taking place in terms of partnerships or mergers and acquisitions (M&As)?

•Has investor confidence been restored in the gene therapy field?


•This report provides market developments across the gene therapy field, including clinical trials, deals, and pipeline investments

•Investment examined on both the industry and financial communities

•Broad discussion on the science behind gene therapies, viral vectors, and gene delivery

•Clinical trials activity examined across phase of development, therapy area, and indication.

•This report offers a deep dive into the synergies behind partnering and acquisition activity

•Deals activity examined across geography, entity type, company, financial advisor, phase of development, therapy area, indication, and mechanism of action

•Pipeline profiles of 20 leading biotech companies developing gene therapies

Key Attribute of Report  

•Identify the key players in the gene therapy market

•Analyze and track the strategies that companies are using to strengthen their position in the gene therapy field; independent source for due diligence

•Organize your sales and marketing strategy to identify companies with proprietary technologies in order to maximize opportunities for licensing, partnership, investment, or takeover

•Understand the flow of investment from capital markets into the gene therapy field

Enquiry about this report visit @

1 Table of Contents  

1.1 List of Tables

1.2 List of Figures

2 Introduction  

2.1 Report Scope

2.2 Companies Mentioned

2.3 Upcoming Reports

2.4 Recently Published Reports

3 Gene Therapy Overview  

3.1 What is Gene Therapy?

3.2 Gene Delivery

4 Market Developments  

4.1 Turning Point: Glybera Approval

4.2 GSK Files Application to the EMA for Gene Therapy for ADA-SCID

4.3 Celladons Reports Negative Results for Mydicar in Advanced Heart Failure

4.4 Spark Initiates Phase I/II Clinical Trial of SPK-CHM for Choroideremia

4.5 FDA Accepts Sangamos IND to Begin Trial of Gene Therapy for Beta-Thalassemia

4.6 Paying for Gene Therapies: Annuity Model

5 Clinical Trials  

5.1 Overview

5.2 Company

5.3 Phase of Development

5.4 Therapy Area

5.5 Indication

5.6 Investigators

6 Company Analysis 

6.1 Overview

6.2 Financial Highlights

6.3 Pipeline Profiles

7 Deals Landscape 

7.1 Overview

7.2 Deal Type

8 Strategic Outlook  

9 Appendix  

9.1 Bibliography

9.2 Research Methodology

9.3 About the Author

9.4 Global Head of Healthcare

9.5 About the Industry Dynamics Team

9.6 Disclosure Information

9.7 Disclaimer

Browse Similar Report: 

BIOSIMILARS - Regulatory Framework and Pipeline Analysis  

Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative biologics are enormously high and even minimal reduction in price will reduce the healthcare spending substantially.

Get More Details @

Hepatitis B Therapeutics in Major Developed Markets to 2021 - Increasing Number of Migrants from High-Prevalence Regions to Drive Market Growth  

Hepatitis B is an infectious liver disease caused by the Hepatitis B Virus (HBV) and characterized by acute or chronic inflammation of the liver. Despite its status as a vaccine-preventable disease, it remains a serious global health concern.

Get More Details @

About Us:  

With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:
Dhananjay Potle
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Direct :+ 1-503-894-6022
Toll Free :+ 1-800-910-6452



SOURCE Big Market Research